Fair Value Measurements (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	9 Months Ended				9 Months Ended
	Mar. 31, 2014	Mar. 31, 2014 Rising Pharmaceuticals Inc. [Member]	Jun. 30, 2013 Rising Pharmaceuticals Inc. [Member]	Mar. 31, 2014 France Company [Member]	Mar. 31, 2014 Foreign Currency Contract [Member]	Mar. 31, 2013 Foreign Currency Contract [Member]	Mar. 31, 2014 Interest Rate Swap [Member] Cash Flow Hedging [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, notional amount					$ 50,566		$ 20,000
Unrealized gains (losses) on hedging activities					75	218
Derivative, interest rate							1.91%
Derivative, expiration date							Dec. 31, 2015
Unrealized loss on interest rate swap	150
Interest rate swap, remaining balance	9,250
Contingent consideration at fair value		$ 5,605	$ 5,346	$ 408